Biggest News Aggregation in the World
📰 Hunterc Smith News

Hunterc Smith News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hunterc Smith. Real-time updates on events, politics, business and more.

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares of the company’s stock after selling 214,773 shares during the period. […]
United States New York Hunterc Smith Zurcher Kantonalbank Zurich Cantonalbank Davidp Meeker Canaccord Genuity Group
Source: wkrb13.com

Rhythm Pharmaceuticals' (RYTM) "Buy" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities analysts also recently commented on RYTM. The Goldman Sachs Group upped their target […]
Davidp Meeker Hunterc Smith Wells Fargo Company Silverarc Capital Management Goldman Sachs Group Barclays Plc

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52.00 at Wells Fargo & Company

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […]
Joseph Shulman Hunterc Smith Rhythm Pharmaceuticals Company Profile Rhythm Pharmaceuticals Rhythm Pharmaceuticals Stock Performance Analyst Recommendations For Rhythm Pharmaceuticals
Source: wkrb13.com

Profund Advisors LLC Sells 19,262 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Profund Advisors LLC trimmed its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 40.9% in the 3rd quarter, Holdings Channel reports. The firm owned 27,818 shares of the company’s stock after selling 19,262 shares during the quarter. Profund Advisors LLC’s holdings in Rhythm Pharmaceuticals were worth $638,000 at the end of […]
Joseph Shulman Hunterc Smith Rhythm Pharmaceuticals Profile Dimensional Fund Advisors Hermes Inc Rhythm Pharmaceuticals Stock Performance
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Down 4.4%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s share price was down 4.4% on Thursday . The stock traded as low as $43.43 and last traded at $46.68. Approximately 90,505 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 686,012 shares. The stock had previously closed at $48.81. […]
Joseph Shulman Hunterc Smith Needham Company Wells Fargo Company Silverarc Capital Management Securities Exchange Commission

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Down 4.4%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded down 4.4% during trading on Thursday . The stock traded as low as $43.43 and last traded at $46.68. 90,505 shares traded hands during trading, a decline of 87% from the average session volume of 686,012 shares. The stock had previously closed at $48.81. Analyst Upgrades […]
United States Hunterc Smith Joseph Shulman Rhythm Pharmaceuticals Stock News Ratings For Rhythm Pharmaceuticals Daily Life Insurance Co

Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells $62,118.42 in Stock

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) CFO Hunter C. Smith sold 1,209 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $51.38, for a total transaction of $62,118.42. Following the transaction, the chief financial officer now directly owns 80,413 shares in […]
Hunterc Smith Rhythm Pharmaceuticals Inc Securities Exchange Commission Wells Fargo Company Needham Company Goldman Sachs Group

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Down 3.6%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded down 3.6% during trading on Thursday . The company traded as low as $44.44 and last traded at $44.79. 59,079 shares were traded during mid-day trading, a decline of 92% from the average session volume of 759,624 shares. The stock had previously closed at $46.46. Analysts […]
United States Joseph Shulman Hunterc Smith Wells Fargo Company Rhythm Pharmaceuticals News Ratings For Rhythm Pharmaceuticals Daily

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science